Mindray – one of the leading global providers of medical devices and solutions

Why is Mindray one of the leading providers of advanced medical technologies in the world today? What is driving the company's rapid growth? What percentage of its annual turnover does Mindray allocate to research and development? You will find the answers in this review.

Founded in 1991, Mindray is one of the leading global providers of medical devices and solutions. It is a company whose mission is to make advanced medical technologies more accessible to all. Mindray specialises and constantly innovates in the fields of:

• Patient Monitoring & Life Support;
• In-Vitro Diagnostics;
• Ultrasound systems.

Figure 1. Distribution of Mindray products and solutions around the world

In China, where Mindray began its active growth, the company's products and solutions can be found in almost 110,000 medical institutions. The company's equipment is used in more than 99% of Class A tertiary hospitals. In China, a total of more than 685,940 devices and 447,000 patient monitoring systems have been installed.

Figure 2. Mindray positions in the world market

Mindray has a reliable network of partners around the world. The company constantly monitors and analyses customer needs, implements advanced technologies and supplies them to the market at competitive prices. The ability to create medical equipment and solutions which precisely meet customer needs is one of the keys to Mindray's success.

Today Mindray products and solutions are available at health care institutions in over 190 countries and regions. In China alone, Mindray equipment is used in almost 110,000 medical institutions and 99% of Class A tertiary hospitals.

Mindray is made up of more than 8,300 professionals, experts in their field, working in countries around the world.

In the USA, 19 of the top 20 hospitals in the country in 2017-2018 used Mindray ultrasound systems.

Mindray maintains a network of R&D centres around the world, including 7 in China, 2 in the USA and 1 in Sweden. Mindray allocates 10 per cent of its turnover to R&D. More than 65% of the engineers developing new devices and equipment have a master's or doctoral degree.

The company has allocated a total area of more than 300,000 m² to its manufacturing centres.

Mindray products and solutions are widely acknowledged by and used at prestigious medical institutions in the USA, the UK, Germany, France, Italy, Spain and other developed countries. Mindray maintains long-term partnerships with many of the world's top-notch medical institutions.

Here are some interesting statistical facts. Mindray products and solutions occupy the following share of these markets:

Patient monitoring systems 

• 3rd place in the world
• 1st place in China

Anaesthesiology 

•   3rd place in the world
• 3rd place in the USA, where 40,000 installations have been performed

Ultrasound systems

• 3rd place in China
• 3rd place in the USA, in healthcare centres
• 5th place in the world

Haematology

• 5th place in the world
• 2nd place in China

Surgical lights, operating tables

• 7th place in the world
• 3rd place in China

Figure 3. In 2016, Mindray was one of the 28 strongest companies in China operating in the world market.

Mindray competes in the world market with the best-known brands and earns leading positions.

Certifications

In 1995, Mindray became the first Chinese medical equipment company to receive TÜV Ps 9001/13485 accreditation.

From 2000 to 2003, Mindray acquired the CE Mark for devices in the fields of Patient Monitoring & Life Support, In-Vitro Diagnostics and Medical Imaging Systems.

Since 2004, the company has acquired FDA 510(k) Clearance for devices in the fields of Patient Monitoring & Life Support, In-Vitro Diagnostics and Medical Imaging Systems.

Mindray carefully monitors every step of the manufacturing process and ensures stringent criteria and traceability throughout the entire process. The company is one of the 5 largest global medical equipment manufacturers and one of the fastest-growing companies.

Mindray's plans:

• To expand production in its main subsidiaries and to strengthen its positions in the world market.
• To expand its worldwide sales network and to ensure its leading positions.
• To create from seven to twelve new products each year and to expand product offerings in various market segments.

Graina is the authorised Mindray representative in the three Baltic countries: Lithuania, Latvia and Estonia. We have already established strong positions in the Lithuanian market, but our ambitious objectives foresee active expansion in Latvia and Estonia, too.